|
|
|
By Benjamin Bayer, bioprocess modeling expert | In-silico tools are ubiquitous in development, but big hurdles prevent them from showing up meaningfully in commercial manufacturing. These tips could help clear them. |
|
|
|
By Michelle Gischewski, KM Consulting-Pharma Intelligence | Specialists in drug product formulation and process development at small biopharmas need to balance scientific knowledge and multidisciplinary know-how across the stages of product development. |
|
|
|
A conversation with Miguelina Matthews, Ph.D., Sanofi | Sanofi has been a vocal of advocate of AI/ML for years. Here's how it's using technology to facilitate the audit process and get to the bottom of deviations faster. |
|
|
|
| Revolution In The EU Pharmaceutical Legislation Ahead | White Paper | By Adam Tuszyner, Mabion | Discover the impact revised pharmaceutical legislation will have on the industry by superseding regulations that have fostered the availability of safe and effective medicines for the past two decades. |
|
|
|
|
|
